Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Armando Patrizio

Showing results (31-40 of 46) with videos related to

Pageof 5
Sort By:
Best Practice & Research. Clinical Endocrinology & Metabolism|February 29, 2020
Graves' disease: Epidemiology, genetic and environmental risk factors and virusesAlessandro Antonelli, Silvia Martina Ferrari, Francesca Ragusa, et al.
Expert Opinion on Pharmacotherapy|August 20, 2024
Recent advances in the use of tyrosine kinase inhibitors against thyroid cancerSilvia Martina Ferrari, Armando Patrizio, Giulio Stoppini, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|February 16, 2020
Graves' disease: Clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapyAlessandro Antonelli, Poupak Fallahi, Giusy Elia, et al.
Current Oncology (Toronto, Ont.)|December 22, 2023
Simultaneous Occurrence of Medullary Thyroid Carcinoma and Papillary Thyroid Carcinoma: A Case Series with Literature ReviewPoupak Fallahi, Armando Patrizio, Giulio Stoppini, et al.
International Journal of Molecular Sciences|May 28, 2022
Combination Strategies Involving Immune Checkpoint Inhibitors and Tyrosine Kinase or BRAF Inhibitors in Aggressive Thyroid CancerFrancesca Ragusa, Silvia Martina Ferrari, Giusy Elia, et al.
International Journal of Molecular Sciences|June 27, 2024
Antineoplastic Effect of ALK Inhibitor Crizotinib in Primary Human Anaplastic Thyroid Cancer Cells with STRN-ALK Fusion In VitroSilvia Martina Ferrari, Francesca Ragusa, Giusy Elia, et al.
Frontiers in Oncology|January 6, 2023
Molecular features of aggressive thyroid cancerGiusy Elia, Armando Patrizio, Francesca Ragusa, et al.
Frontiers in Endocrinology|January 9, 2019
Antineoplastic Effect of Lenvatinib and Vandetanib in Primary Anaplastic Thyroid Cancer Cells Obtained From Biopsy or Fine Needle AspirationSilvia Martina Ferrari, Concettina La Motta, Giusy Elia, et al.
Journal of Clinical Medicine|April 13, 2023
Thyroid Metastasis from Primary Breast CancerArmando Patrizio, Silvia Martina Ferrari, Giulio Stoppini, et al.
Frontiers in Endocrinology|July 19, 2024
Liquid L-T4 therapy in hypothyroid patients with gastric diseases, an observational studyPoupak Fallahi, Francesca Ragusa, Armando Patrizio, et al.
Pageof 5

Showing results (31-40 of 46) with videos related to

Sort By:
Pageof 5
Best Practice & Research. Clinical Endocrinology & Metabolism|February 29, 2020
Graves' disease: Epidemiology, genetic and environmental risk factors and virusesAlessandro Antonelli, Silvia Martina Ferrari, Francesca Ragusa, et al.
Expert Opinion on Pharmacotherapy|August 20, 2024
Recent advances in the use of tyrosine kinase inhibitors against thyroid cancerSilvia Martina Ferrari, Armando Patrizio, Giulio Stoppini, et al.
Best Practice & Research. Clinical Endocrinology & Metabolism|February 16, 2020
Graves' disease: Clinical manifestations, immune pathogenesis (cytokines and chemokines) and therapyAlessandro Antonelli, Poupak Fallahi, Giusy Elia, et al.
Current Oncology (Toronto, Ont.)|December 22, 2023
Simultaneous Occurrence of Medullary Thyroid Carcinoma and Papillary Thyroid Carcinoma: A Case Series with Literature ReviewPoupak Fallahi, Armando Patrizio, Giulio Stoppini, et al.
International Journal of Molecular Sciences|May 28, 2022
Combination Strategies Involving Immune Checkpoint Inhibitors and Tyrosine Kinase or BRAF Inhibitors in Aggressive Thyroid CancerFrancesca Ragusa, Silvia Martina Ferrari, Giusy Elia, et al.
International Journal of Molecular Sciences|June 27, 2024
Antineoplastic Effect of ALK Inhibitor Crizotinib in Primary Human Anaplastic Thyroid Cancer Cells with STRN-ALK Fusion In VitroSilvia Martina Ferrari, Francesca Ragusa, Giusy Elia, et al.
Frontiers in Oncology|January 6, 2023
Molecular features of aggressive thyroid cancerGiusy Elia, Armando Patrizio, Francesca Ragusa, et al.
Frontiers in Endocrinology|January 9, 2019
Antineoplastic Effect of Lenvatinib and Vandetanib in Primary Anaplastic Thyroid Cancer Cells Obtained From Biopsy or Fine Needle AspirationSilvia Martina Ferrari, Concettina La Motta, Giusy Elia, et al.
Journal of Clinical Medicine|April 13, 2023
Thyroid Metastasis from Primary Breast CancerArmando Patrizio, Silvia Martina Ferrari, Giulio Stoppini, et al.
Frontiers in Endocrinology|July 19, 2024
Liquid L-T4 therapy in hypothyroid patients with gastric diseases, an observational studyPoupak Fallahi, Francesca Ragusa, Armando Patrizio, et al.
Pageof 5